INDSWIFT LABORATORIES
|
INDSWIFT LABORATORIES Last 5 Year Balance Sheet History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹60 Cr | ₹60 Cr | ₹60 Cr | ₹60 Cr | ₹48 Cr |
Equity - Authorised | ₹60 Cr | ₹60 Cr | ₹60 Cr | ₹60 Cr | ₹60 Cr |
Equity - Issued | ₹59 Cr | ₹59 Cr | ₹59 Cr | ₹59 Cr | ₹48 Cr |
Equity Paid Up | ₹59 Cr | ₹59 Cr | ₹59 Cr | ₹59 Cr | ₹48 Cr |
Equity Shares Forfeited | ₹0.72 Cr | ₹0.72 Cr | ₹0.72 Cr | ₹0.72 Cr | ₹0.72 Cr |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
Share Warrants & Outstandings | - | - | - | - | - |
Total Reserves | ₹622 Cr | ₹541 Cr | ₹544 Cr | ₹581 Cr | ₹540 Cr |
Securities Premium | ₹307 Cr | ₹307 Cr | ₹307 Cr | ₹307 Cr | ₹243 Cr |
Capital Reserves | ₹-1.77 Cr | ₹-34 Cr | ₹-33 Cr | - | - |
Profit & Loss Account Balance | ₹-29 Cr | ₹-78 Cr | ₹-76 Cr | ₹-74 Cr | ₹-52 Cr |
General Reserves | ₹165 Cr | ₹152 Cr | ₹138 Cr | ₹123 Cr | ₹109 Cr |
Other Reserves | ₹181 Cr | ₹194 Cr | ₹208 Cr | ₹224 Cr | ₹239 Cr |
Reserve excluding Revaluation Reserve | ₹439 Cr | ₹345 Cr | ₹333 Cr | ₹356 Cr | ₹300 Cr |
Revaluation reserve | ₹183 Cr | ₹196 Cr | ₹211 Cr | ₹225 Cr | ₹240 Cr |
Shareholder's Funds | ₹682 Cr | ₹601 Cr | ₹604 Cr | ₹641 Cr | ₹588 Cr |
Minority Interest | - | ₹-0.11 Cr | ₹-0.09 Cr | - | - |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | ₹753 Cr | ₹848 Cr | ₹884 Cr | ₹886 Cr | ₹954 Cr |
Non Convertible Debentures | ₹752 Cr | ₹797 Cr | ₹794 Cr | ₹776 Cr | ₹750 Cr |
Converible Debentures & Bonds | - | - | ₹8.72 Cr | - | ₹75 Cr |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | - | - | - | - | - |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | ₹1.09 Cr | ₹51 Cr | ₹82 Cr | ₹110 Cr | ₹128 Cr |
Unsecured Loans | - | - | - | ₹4.93 Cr | ₹12 Cr |
Fixed Deposits - Public | - | - | - | ₹4.93 Cr | ₹12 Cr |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | - | - | - | - | - |
Deferred Tax Assets / Liabilities | ₹-30 Cr | ₹-52 Cr | ₹-60 Cr | ₹-78 Cr | ₹-79 Cr |
Deferred Tax Assets | ₹74 Cr | ₹101 Cr | ₹134 Cr | ₹165 Cr | ₹182 Cr |
Deferred Tax Liability | ₹44 Cr | ₹49 Cr | ₹73 Cr | ₹87 Cr | ₹104 Cr |
Other Long Term Liabilities | ₹0.66 Cr | ₹0.66 Cr | ₹0.66 Cr | ₹0.66 Cr | ₹0.23 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹18 Cr | ₹17 Cr | ₹16 Cr | ₹15 Cr | ₹14 Cr |
Total Non-Current Liabilities | ₹741 Cr | ₹814 Cr | ₹840 Cr | ₹828 Cr | ₹901 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹204 Cr | ₹176 Cr | ₹139 Cr | ₹135 Cr | ₹127 Cr |
Sundry Creditors | ₹204 Cr | ₹176 Cr | ₹139 Cr | ₹135 Cr | ₹127 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹106 Cr | ₹89 Cr | ₹81 Cr | ₹73 Cr | ₹136 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹15 Cr | ₹15 Cr | ₹18 Cr | ₹9.35 Cr | ₹3.91 Cr |
Interest Accrued But Not Due | ₹9.58 Cr | ₹10.00 Cr | - | - | ₹33 Cr |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹81 Cr | ₹64 Cr | ₹63 Cr | ₹64 Cr | ₹100 Cr |
Short Term Borrowings | ₹49 Cr | ₹64 Cr | ₹93 Cr | ₹115 Cr | ₹93 Cr |
Secured ST Loans repayable on Demands | ₹45 Cr | ₹59 Cr | ₹61 Cr | ₹62 Cr | ₹64 Cr |
Working Capital Loans- Sec | ₹45 Cr | ₹59 Cr | ₹61 Cr | ₹62 Cr | ₹64 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹-40 Cr | ₹-55 Cr | ₹-28 Cr | ₹-9.76 Cr | ₹-35 Cr |
Short Term Provisions | ₹12 Cr | ₹5.39 Cr | ₹0.98 Cr | - | ₹0.31 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹12 Cr | ₹5.39 Cr | ₹0.98 Cr | - | ₹0.31 Cr |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | - | - | - | - | - |
Total Current Liabilities | ₹371 Cr | ₹334 Cr | ₹315 Cr | ₹323 Cr | ₹356 Cr |
Total Liabilities | ₹1,794 Cr | ₹1,749 Cr | ₹1,758 Cr | ₹1,792 Cr | ₹1,845 Cr |
ASSETS | |||||
Gross Block | ₹1,331 Cr | ₹1,317 Cr | ₹1,302 Cr | ₹1,359 Cr | ₹1,379 Cr |
Less: Accumulated Depreciation | ₹746 Cr | ₹689 Cr | ₹563 Cr | ₹516 Cr | ₹478 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹585 Cr | ₹628 Cr | ₹739 Cr | ₹843 Cr | ₹901 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹7.71 Cr | ₹9.31 Cr | ₹11 Cr | ₹3.80 Cr | ₹13 Cr |
Non Current Investments | ₹30 Cr | ₹29 Cr | ₹36 Cr | ₹17 Cr | ₹31 Cr |
Long Term Investment | ₹30 Cr | ₹29 Cr | ₹36 Cr | ₹17 Cr | ₹31 Cr |
Quoted | - | - | - | - | - |
Unquoted | ₹30 Cr | ₹29 Cr | ₹36 Cr | ₹17 Cr | ₹31 Cr |
Long Term Loans & Advances | ₹4.17 Cr | ₹3.96 Cr | ₹6.11 Cr | ₹57 Cr | ₹57 Cr |
Other Non Current Assets | - | - | - | - | - |
Total Non-Current Assets | ₹630 Cr | ₹674 Cr | ₹814 Cr | ₹929 Cr | ₹1,009 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | - | - | - | - | - |
Quoted | - | - | - | - | - |
Unquoted | - | - | - | - | - |
Inventories | ₹439 Cr | ₹429 Cr | ₹376 Cr | ₹343 Cr | ₹317 Cr |
Raw Materials | ₹108 Cr | ₹108 Cr | ₹94 Cr | ₹82 Cr | ₹69 Cr |
Work-in Progress | ₹189 Cr | ₹191 Cr | ₹166 Cr | ₹171 Cr | ₹142 Cr |
Finished Goods | ₹128 Cr | ₹117 Cr | ₹107 Cr | ₹81 Cr | ₹97 Cr |
Packing Materials | - | - | - | - | - |
Stores Ā and Spare | ₹13 Cr | ₹11 Cr | ₹9.18 Cr | ₹8.21 Cr | ₹7.94 Cr |
Other Inventory | - | - | - | - | - |
Sundry Debtors | ₹505 Cr | ₹455 Cr | ₹432 Cr | ₹396 Cr | ₹351 Cr |
Debtors more than Six months | - | - | - | - | - |
Debtors Others | ₹505 Cr | ₹455 Cr | ₹432 Cr | ₹396 Cr | ₹351 Cr |
Cash and Bank | ₹18 Cr | ₹21 Cr | ₹12 Cr | ₹11 Cr | ₹30 Cr |
Cash in hand | ₹0.78 Cr | ₹0.20 Cr | ₹0.52 Cr | ₹0.30 Cr | ₹0.97 Cr |
Balances at Bank | ₹17 Cr | ₹21 Cr | ₹11 Cr | ₹10 Cr | ₹29 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹9.02 Cr | ₹17 Cr | ₹56 Cr | ₹39 Cr | ₹42 Cr |
Interest accrued on Investments | - | - | - | - | - |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | ₹4.07 Cr | ₹5.03 Cr | ₹2.18 Cr | ₹1.33 Cr | ₹1.29 Cr |
Other current_assets | ₹4.95 Cr | ₹12 Cr | ₹54 Cr | ₹37 Cr | ₹41 Cr |
Short Term Loans and Advances | ₹192 Cr | ₹152 Cr | ₹66 Cr | ₹74 Cr | ₹97 Cr |
Advances recoverable in cash or in kind | ₹61 Cr | ₹48 Cr | ₹53 Cr | ₹11 Cr | ₹12 Cr |
Advance income tax and TDS | ₹4.96 Cr | ₹4.55 Cr | ₹4.06 Cr | ₹3.98 Cr | ₹3.99 Cr |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹126 Cr | ₹99 Cr | ₹8.47 Cr | ₹60 Cr | ₹81 Cr |
Total Current Assets | ₹1,163 Cr | ₹1,073 Cr | ₹942 Cr | ₹863 Cr | ₹836 Cr |
Net Current Assets (Including Current Investments) | ₹792 Cr | ₹739 Cr | ₹627 Cr | ₹540 Cr | ₹480 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹1,794 Cr | ₹1,749 Cr | ₹1,758 Cr | ₹1,792 Cr | ₹1,845 Cr |
Contingent Liabilities | ₹7.97 Cr | ₹36 Cr | ₹40 Cr | ₹23 Cr | ₹52 Cr |
Total Debt | ₹852 Cr | ₹943 Cr | ₹1,005 Cr | ₹1,031 Cr | ₹1,115 Cr |
Book Value | 84.25 | 68.33 | 66.35 | 70.21 | 73.01 |
Adjusted Book Value | 84.25 | 68.33 | 66.35 | 70.21 | 73.01 |
Compare Balance Sheet of peers of INDSWIFT LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDSWIFT LABORATORIES | ₹699.9 Cr | -10.2% | -15.4% | 70.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹365,311.0 Cr | 3% | 2.3% | 68.2% | Stock Analytics | |
CIPLA | ₹108,623.0 Cr | 2.5% | 0.4% | 71.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,134.3 Cr | -0.2% | -4.9% | 40.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹97,408.4 Cr | -1.6% | -7% | 23.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹92,794.9 Cr | 5% | 10.4% | 109.1% | Stock Analytics |
INDSWIFT LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDSWIFT LABORATORIES | -10.2% |
-15.4% |
70.5% |
SENSEX | -2.6% |
-0% |
21% |
You may also like the below Video Courses